Market Place
Sourcing Support
Quantum Cyber Aligns Strategy With National Cyber Security
17 Mar 2026 //
GLOBENEWSWIRE
Quantum Cyber Changes Nasdaq Ticker to QUCY
13 Mar 2026 //
GLOBENEWSWIRE
Mainz Biomed Names Robert Liscouski Chairman Of Board
11 Mar 2026 //
GLOBENEWSWIRE
Mainz Biomed Reveals $6M Private Placement And Strategic Update
17 Feb 2026 //
GLOBENEWSWIRE
Mainz Biomed at 38th GARPS Gastroenterological Meeting
10 Nov 2025 //
GLOBENEWSWIRE
Mainz Biomed to Present CRC Screening Future at WEO Meeting
30 Sep 2025 //
GLOBENEWSWIRE
Mainz Biomed Starts Study on Biomarker Panel in Pancreatic Cancer
10 Jun 2025 //
GLOBENEWSWIRE
Mainz Biomed Prices $4.0M Follow-On Offering of Shares
19 May 2025 //
GLOBENEWSWIRE
Mainz Biomed Announces Interim Results for eAArly Detect 2 Study
16 May 2025 //
GLOBENEWSWIRE
Mainz Biomed Reports 2024 Financial Results and Corporate Update
01 Apr 2025 //
GLOBENEWSWIRE
Mainz Biomed Urges Shift From Screening To Prevention In CRC
03 Mar 2025 //
GLOBENEWSWIRE
Mainz Biomed Regains Compliance With Nasdaq Listing Requirements
27 Jan 2025 //
PHARMAWEB
Mainz Biomed Initiates Study On Next-Gen Test For Advanced Adenomas
21 Jan 2025 //
PHARMAWEB
Mainz Biomed Launches Enhanced ColoAlert For Better Screening Efficiency
25 Jul 2024 //
GLOBENEWSWIRE
Mainz Biomed Provides Half Year 2024 Corporate Update
02 Jul 2024 //
GLOBENEWSWIRE
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
03 Jun 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Results of 2024 Annual General Meeting
31 May 2024 //
GLOBENEWSWIRE
Mainz Biomed: Largest Colorectal Cancer Screening Data At ASCO 2024
28 May 2024 //
GLOBENEWSWIRE
Mainz Biomed Awarded Poster At DDW Ahead Of FDA Trial
20 May 2024 //
GLOBENEWSWIRE
Mainz Biomed To Present Colorectal Cancer Screening Study At DDW 2024
07 May 2024 //
GLOBENEWSWIRE
Mainz Biomed Reports Full Year 2023 Financial Results
09 Apr 2024 //
GLOBENEWSWIRE
Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in CCT
19 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - New Laboratory
18 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed: Webinar on Early Detection of Colorectal Cancer
18 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed Presents ColoAlert® at UDH Congress 2024
12 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed Partners with Trusted Health Advisors
05 Mar 2024 //
GLOBENEWSWIRE
Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart
27 Feb 2024 //
GLOBENEWSWIRE
Mainz Biomed Establishes Strategic Partnership with TomaLab
21 Feb 2024 //
GLOBENEWSWIRE
Mainz Biomed Provides Year-End Corporate Review 2023
09 Jan 2024 //
GLOBENEWSWIRE
Mainz Biomed and Bantleon Partner to Elevate Corporate Health
19 Dec 2023 //
GLOBENEWSWIRE
Mainz Showcases ColoAlert at Two Prominent Gastroenterology Conferences
12 Dec 2023 //
GLOBENEWSWIRE
Mainz Biomed™s Presentation at 35th Annual Piper Sandler Healthcare Conference
29 Nov 2023 //
GLOBENEWSWIRE
Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
20 Nov 2023 //
GLOBENEWSWIRE
Mainz Biomed Reports Third Quarter 2023 Financial Results
16 Nov 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Closing of $5.0 million Registered Direct Offering
15 Nov 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Pricing of $5.0 million Registered Direct Offering
13 Nov 2023 //
GLOBENEWSWIRE
Mainz Biomed Partners with Liquid Biosciences to Harness the Power of AI
09 Nov 2023 //
GLOBENEWSWIRE
Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign
31 Oct 2023 //
GLOBENEWSWIRE
Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
26 Oct 2023 //
GLOBENEWSWIRE
Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
18 Oct 2023 //
GLOBENEWSWIRE
Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
11 Oct 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
04 Oct 2023 //
GLOBENEWSWIRE
Mainz Announces Financial Half Year Results 2023 and Provides Corporate Update
15 Aug 2023 //
GLOBENEWSWIRE
Mainz Biomed Expands into Romania Through Partnership with Bioclinica
20 Jun 2023 //
GLOBENEWSWIRE
Mainz Biomed Expands Commercial Footprint into Poland
31 May 2023 //
GLOBENEWSWIRE
Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign
24 May 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces 1Q 2023 FYR and Provides Corporate Update
16 May 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network
03 May 2023 //
GLOBENEWSWIRE
Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum
27 Apr 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Partnership with the Instituto de Microecologia
26 Apr 2023 //
GLOBENEWSWIRE
Mainz Biomed to Present at Sidoti Virtual Investor Conference March 22-23
21 Mar 2023 //
GLOBENEWSWIRE
Mainz Biomed Announces Partnership with Labor Staber
15 Mar 2023 //
GLOBENEWSWIRE
Mainz Biomed Launches Number of Educational Events in Germany
08 Mar 2023 //
GLOBENEWSWIRE
Mainz Biomed to Appear on ClearThink Virtual Live Event
28 Feb 2023 //
GLOBENEWSWIRE
Mainz Acquires Property Portfolio for Colorectal Cancer Diagnostic Test Program
21 Feb 2023 //
GLOBENEWSWIRE
Mainz Expands European Commercial Footprint and Enters Markets in Spain and UK
15 Feb 2023 //
GLOBENEWSWIRE
Mainz Biomed explores markets in UK and Spain for ColoAlert
15 Feb 2023 //
PHARMATIMES
Mainz Biomed Launches Corporate Health Program in Germany for ColoAlert
18 Jan 2023 //
GLOBENEWSWIRE
Mainz Biomed Enrolls First Patient in eAArly DETECT Study Evaluating Integration
20 Dec 2022 //
GLOBENEWSWIRE
Mainz Biomed Announces IRB Approval and Initiation of US Pivotal FDA Study
06 Dec 2022 //
GLOBENEWSWIRE
